Brief report · 30 Jun 2026
Conference abstractPublished 6 Dec 2017
Aminocarbazole alkaloid derivatives as potential modulators of p53mutants
University of Porto, Portugal
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The tumor suppressor protein p53 is a major regulator of key cellular processes, including cell cycle arrest, apoptosis, DNA repair, stemness, invasion and migration. TP53 is the most commonly mutated gene in human cancer. In fact, over half of human cancers contain p53 mutations, particularly missense mutations, preferentially localized within the p53 DNAbinding domain. Mutant p53 is frequently associated with patient poor prognosis due to more aggressive tumor phenotypes, particularly increased proliferation, metastasis and resistance to therapy (REF). Heptaphylline is a carbazole alkaloid, isolated from Clausena harmandiana with promising antitumor effects. Herein, the semisynthesis of heptaphylline and two related secondary metabolites was performed for the purposes of enhancing their antitumor activity and improve physico-chemical properties. The molecular modifications were based on introduction of amine derivative moieties, which are present in some known p53 modulators. Reductive aminations using sodium triacetobohydride in acidic conditions were applied on three natural isolated carbaldehyde carbazole alkaloids to obtain a small library of amino derivatives. Both natural isolated carbazoles and amino derivatives were tested for their ability to inhibit tumor cell growth in human tumor cell lines expressing different forms of p53 (wild-type, mutants). Moreover, using a yeast-screening assay (REF), it was investigated the ability of heptaphylline to reactivate several mutant p53 forms with high prevalence in human cancer. Natural occuring carbazoles and the first series of amines investigated showed promising tumor cell growth inhibitory effects (GI50<10Ã?¼M). Also, some derivatives reestablished the wild-type-like activity to several mutant p53 in yeast, behaving as potential reactivators of mutant p53. These results suggest the discovery of a potential lead compound for the development of anticancer agents p53 modulators.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Solida Long”
- BylineArticles whose byline prints “Joana Loureiro”
- BylineArticles whose byline prints “Nanthicha Thongdee”
- BylineArticles whose byline prints “Madalena M Pinto”
- BylineArticles whose byline prints “Ploenthip Puthongking”
- BylineArticles whose byline prints “Lucília Saraiva”
- BylineArticles whose byline prints “Emilia Sousa”
